9 results

• Whistleblower Lawsuit Over AstraZeneca Off-Label Marketing Ends in $2.4M Verdict

  June 24, 2021

  Irvin Jackson

  An Oregon jury wants AstraZeneca to pay $2.4 million for violating a former employee's whistleblower rights after she claimed the company was illegally marketing the asthma drug Symbicort.

• COPD Drugs Linked To Increased Cardiovascular Health Risks: Study

  January 9, 2018

  Irvin Jackson

  Some COPD treatments can significantly increase the risk of severe heart problems after just one month of treatment, according to the findings of a new study.

• FDA Removes Advair, Symbicort Boxed Warnings For Death Risks

  December 22, 2017

  Irvin Jackson

  The FDA is removing a black box warning from certain asthma inhalers, saying that evidence shows they do not carry the increased risk of severe asthma side effects and death that older research indicated.

• Spiriva, Serevent COPD Drugs Could Increase Heart Problem Risk: Study

  May 24, 2013

  Irvin Jackson

  The findings of a new study resurrects concerns that some long-acting inhalers used to treat chronic pulmonary obstructive disease (COPD),...

• Asthma Drug Birth Defect Risk Seen When Used in Pregnancy: Study

  January 26, 2012

  Staff Writers

  A new study suggests a link between specific birth defects and asthma medication use during pregnancy, raising concerns about the...

• Studies Ordered for Side Effects of Symbicort, Advair Diskus, Dulera, Foradil

  April 19, 2011

  Staff Writers

  Federal drug regulators have ordered that new studies be done to examine potential safety problems with a number of asthma...

• Risk of Problems from Asthma Drugs Lead to New FDA Warnings

  February 19, 2010

  Staff Writers

  Federal regulators have moved to restrict the use of Advair, Symbicort, Foradil and Serevent, after determining that side effects of...

• FDA Panel Indicates Foradil and Serevent Should Not Be Used for Asthma

  December 12, 2008

  AboutLawsuits

  An FDA advisory panel, which met Wednesday and Thursday to review long-acting asthma inhaler risks, has indicated that Foradil and...

• Asthma Inhalers Foradil, Serevent, Symbicort and Advair Increase Risk of Death: FDA Officials Warn

  December 9, 2008

  AboutLawsuits

  Several FDA officials have warned that because side effects of Advair, Serevent, Foradil and Symbicort may increase the risk of...